Endra Life Sciences Inc. Announces Resignation of David Wells as the Company's Chief Financial Officer, Effective June 18, 2021
June 15, 2021 at 02:01 pm
ENDRA Life Sciences Inc. announced resignation of David Wells as the Company's Chief Financial Officer, effective June 18, 2021. On June 11, 2021, the Companys Board of Directors appointed Irina Pestrikova as Senior Director, Finance, effective upon Mr. Wells resignation. Ms. Pestrikova will serve as the Companys principal financial officer in such role.